The role of epithelial-mesenchymal interactions in tissue repair, fibrogenesis and carcinogenesis

by Do, D.V., Mukhopadhyay, A., Lim, I.J., Phan, T.T.
Published 2011

mTOR as a potential therapeutic target for treatment of keloids and excessive scars

by Ong, C.T., Khoo, Y.T., Mukhopadhyay, A., Do, D.V., Lim, I.J., Aalami, O.
Published 2011

Effects of acute severe acute respiratory syndrome coronavirus 2 infection on male hormone profile, ACE2 and TMPRSS2 expression, and potential for transmission of severe acute resp...

by Huang, Z, Do, DV, Beh, D, Lee, CK, Yan, B, Foo, R, Tambyah, PA
Published 2022

Comparative proteomic analysis between normal skin and keloid scar

by Ong, C.T., Khoo, Y.T., Mukhopadhyay, A., Masilamani, J., Lim, I.J., Phan, T.T., Do, D.V.
Published 2011

Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis

by Khoo, Y.T., Ong, C.T., Do, D.V., Lim, I.J., Phan, T.T., Mukhopadhyay, A., Han, H.C.
Published 2011

Epithelial-mesenchymal interactions in keloid pathologenesis modulate vascular endothelial growth factor expression and secretion

by Ong, C.T., Khoo, Y.T., Lim, I.J., Phan, T.T., Mukhopadhyay, A., Tan, E.K., Han, H.C., Do, D.V.
Published 2011

Syndecan-2 and decorin: Proteoglycans with a difference-implications in keloid pathogenesis

by Mukhopadhyay, A., Do, D.V., Khoo, A., Ong, C.T., Lim, I.J., Phan, T.T., Wong, M.Y., Chan, S.Y., Cheong, H.H.
Published 2011

Syndecan-2 and decorin: Proteoglycans with a difference-implications in keloid pathogenesis

by Mukhopadhyay, A., Wong, M.Y., Chan, S.Y., Do, D.V., Khoo, A., Ong, C.T., Cheong, H.H., Lim, I.J., Phan, T.T.
Published 2014

Hepatoma-derived growth factor and its role in keloid pathogenesis

by Ooi, B.N.S., Mukhopadhyay, A., Masilamani, J., Do, D.V., Lim, C.P., Cao, X.M., Lim, I.J., Mao, L., Ren, H.N., Nakamura, H., Phan, T.T.
Published 2014

The role of stem cell factor and c-KIT in keloid pathogenesis: Do tyrosine kinase inhibitors have a potential therapeutic role?

by Mukhopadhyay, A., Do, D.V., Ong, C.T., Khoo, Y.T., Masilamani, J., Chan, S.Y., Vincent, A.S., Wong, P.K., Lim, C.P., Cao, X., Lim, I.J., Phan, T.T.
Published 2014

The STAT3 Target Mettl8 Regulates Mouse ESC Differentiation via Inhibiting the JNK Pathway

by Gu, H., Do, D.V., Liu, X., Xu, L., Su, Y., Nah, J.M., Wong, Y., Li, Y., Sheng, N., Tilaye, G.A., Yang, H., Guo, H., Yan, J., Fu, X.-Y.
Published 2021

A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo

by Do, D.V., Ueda, J., Messerschmidt, D.M., Lorthongpanich, C., Zhou, Y., Feng, B., Guo, G., Lin, P.J., Hossain, M.Z., Zhang, W., Moh, A., Wu, Q., Robson, P., Ng, H.H., Poellinger, L., Knowles, B.B., Solter, D., Fu, X.-Y.
Published 2014